BIOMAT Database Logo BIOMAT Database Logo

When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. 1996

C Elliott, and D M Samson, and S Armitage, and M P Lyttelton, and D McGuigan, and R Hargreaves, and C Giles, and G Abrahamson, and Z Abboudi, and M Brennan, and E J Kanfer
Charing Cross Hospital, London, United Kingdom.

OBJECTIVE To evaluate whether the CD34+ yield from a single peripheral-blood stem-cell (PBSC) harvest could be predicted by measurement of the patient's circulating WBC and CD34+ cell concentrations on the day before harvest. METHODS Thirty-nine patients with hematologic or nonhematologic malignancy underwent 41 stem-cell mobilization episodes with cytotoxic chemotherapy and/or granulocyte colony-stimulating factor (G-CSF), and a total of 63 leukapheresis procedures were performed. Peripheral-blood samples were analyzed for WBC and CD34+ cell concentration both on the day before and the day of leukapheresis. RESULTS The median WBC and CD34+ concentrations on the day preceding leukapheresis were 10.0 x 10(9)/L (range, 0.4 to 44.4) and 24.9 x 10(6)/L (range, 0.1 to 349.4), respectively. On the day of harvest, the corresponding figures were 15.1 x 10(9)/L (range, 1.5 to 52.6) and 29.3 x 10(6)/L (range, 0.1 to 543.1), respectively. The median CD34+ cell number collected in a single leukapheresis was 2.6 x 10(6)/kg body weight (range, 0.1 to 26.1). Both the preceding day (r = .84, P < .001) and harvest day (r = .95, P < .001) CD34+ circulating concentrations correlated significantly with the number of CD34+ cells per kilogram collected at leukapheresis. The correlation between CD34+ cells per kilogram collected and harvest day WBC count was also significant (r = .43, P <.001), but with the preceding day WBC count was nonsignificant. CONCLUSIONS The number of CD34+ cells harvested in a single leukapheresis can be predicted by measurement of the preceding day peripheral-blood circulating CD34+ concentration, and on the basis of these data a table of probable CD34+ cell yield has been constructed. This correlation may facilitate the efficient organization of leukapheresis procedures.

UI MeSH Term Description Entries
D007937 Leukapheresis The preparation of leukocyte concentrates with the return of red cells and leukocyte-poor plasma to the donor. Leukocytapheresis,Leukopheresis,Lymphapheresis,Lymphocytapheresis,Leukocytopheresis,Lymphocytopheresis,Lymphopheresis,Leukaphereses,Leukocytaphereses,Leukocytophereses,Leukophereses,Lymphaphereses,Lymphocytaphereses,Lymphocytophereses,Lymphophereses
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D006402 Hematologic Diseases Disorders of the blood and blood forming tissues. Blood Diseases,Hematological Diseases,Blood Disease,Disease, Blood,Disease, Hematologic,Disease, Hematological,Diseases, Blood,Diseases, Hematologic,Diseases, Hematological,Hematologic Disease,Hematological Disease
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D016179 Granulocyte Colony-Stimulating Factor A glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines. Colony-Stimulating Factor, Granulocyte,G-CSF,Myeloid Growth Factor,Colony Stimulating Factor, Granulocyte,Factor, Granulocyte Colony-Stimulating,Factor, Myeloid Growth,Granulocyte Colony Stimulating Factor,Growth Factor, Myeloid

Related Publications

C Elliott, and D M Samson, and S Armitage, and M P Lyttelton, and D McGuigan, and R Hargreaves, and C Giles, and G Abrahamson, and Z Abboudi, and M Brennan, and E J Kanfer
Prediction of engraftment after peripheral blood stem cell transplantation by CD34-positive cells in grafts.
August 1993, Acta paediatrica Japonica : Overseas edition,
C Elliott, and D M Samson, and S Armitage, and M P Lyttelton, and D McGuigan, and R Hargreaves, and C Giles, and G Abrahamson, and Z Abboudi, and M Brennan, and E J Kanfer
Comparison of peripheral blood CD34+ concentration, colony-forming units granulocyte-macrophage and mononuclear cells in leukapheresed product for the prediction of peripheral blood CD34+ cell yield harvest.
May 1997, Annals of the Academy of Medicine, Singapore,
C Elliott, and D M Samson, and S Armitage, and M P Lyttelton, and D McGuigan, and R Hargreaves, and C Giles, and G Abrahamson, and Z Abboudi, and M Brennan, and E J Kanfer
[CDw90 (Thy-1) expression on CD34 positive cells in peripheral blood stem cell harvest].
January 1997, [Rinsho ketsueki] The Japanese journal of clinical hematology,
C Elliott, and D M Samson, and S Armitage, and M P Lyttelton, and D McGuigan, and R Hargreaves, and C Giles, and G Abrahamson, and Z Abboudi, and M Brennan, and E J Kanfer
Prediction model for CD34 positive cell yield in peripheral blood stem cell collection on the fourth day after G-CSF administration in healthy donors.
July 2013, International journal of hematology,
C Elliott, and D M Samson, and S Armitage, and M P Lyttelton, and D McGuigan, and R Hargreaves, and C Giles, and G Abrahamson, and Z Abboudi, and M Brennan, and E J Kanfer
[Kinetics of peripheral blood CD34-positive cells and optimal timing of blood stem cell harvest after urological anticancer chemotherapy].
October 1996, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
C Elliott, and D M Samson, and S Armitage, and M P Lyttelton, and D McGuigan, and R Hargreaves, and C Giles, and G Abrahamson, and Z Abboudi, and M Brennan, and E J Kanfer
[Mobilization and harvest of peripheral blood stem cells].
July 1995, Rinsho byori. The Japanese journal of clinical pathology,
C Elliott, and D M Samson, and S Armitage, and M P Lyttelton, and D McGuigan, and R Hargreaves, and C Giles, and G Abrahamson, and Z Abboudi, and M Brennan, and E J Kanfer
Monitoring of kinetics of CD34 positive cells by immunomagnetic beads during peripheral blood stem cell harvest for autotransplantation.
January 1992, Progress in clinical and biological research,
C Elliott, and D M Samson, and S Armitage, and M P Lyttelton, and D McGuigan, and R Hargreaves, and C Giles, and G Abrahamson, and Z Abboudi, and M Brennan, and E J Kanfer
Daily measurements of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery.
February 1997, Journal of hematotherapy,
C Elliott, and D M Samson, and S Armitage, and M P Lyttelton, and D McGuigan, and R Hargreaves, and C Giles, and G Abrahamson, and Z Abboudi, and M Brennan, and E J Kanfer
The phenotypic profile of CD34-positive peripheral blood stem cells in different mobilization regimens.
December 2000, British journal of haematology,
C Elliott, and D M Samson, and S Armitage, and M P Lyttelton, and D McGuigan, and R Hargreaves, and C Giles, and G Abrahamson, and Z Abboudi, and M Brennan, and E J Kanfer
CD34-positive cell yield in peripheral blood of cancer patients during radiation therapy.
January 1998, Radiation medicine,
Copied contents to your clipboard!